title: Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice.
abstract: BACKGROUND
  Circadian patterns of cardiovascular vulnerability were well characterized, with a peak incidence of acute myocardial infarction and stroke secondary to atherosclerosis in the morning, which showed the circadian clock may take part in the pathological process of atherosclerosis induced by hyperlipidemia. Hence, the effect of hyperlipidemia on the expression of circadian genes was investigated in atherosclerotic mouse model.
  
  
  RESULTS
  In apoE-/-mice on regular chow or high-fat diet, an atherosclerotic mouse model induced by heperlipidemia, we found that the peak concentration of serum lipids was showed four or eight hours later in apoE-/- mice, compared to C57BL/6J mice. During the artificial light period, a reduce in circulating level of serum lipids corresponded with the observed increase of the expression levels of some the transcription factors involved in lipid metabolism, such as PPARalpha and RXRalpha. Meanwhile, the expression of circadian genes was changed following with amplitude reduced or the peak mRNA level delayed.
  
  
  CONCLUSIONS
  Our studies indicated that heperlipidemia altered both the rhythmicity and expression of circadian genes. Diet-induced circadian disruption may affect the process of atherosclerosis and some acute cardiovascular disease.
authors.affiliation: Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai 200032, PR China. hlkkekexili@gmail.com
authors.forename: Likun
authors.initials: L
authors.lastname: Hou
authors.forename: Chao
authors.initials: C
authors.lastname: Lu
authors.forename: Yang
authors.initials: Y
authors.lastname: Huang
authors.forename: Sifeng
authors.initials: S
authors.lastname: Chen
authors.forename: Luchun
authors.initials: L
authors.lastname: Hua
authors.forename: Ruizhe
authors.initials: R
authors.lastname: Qian
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000473:pathology; D001057:Apolipoproteins E / Q000097:blood / Q000172:deficiency* / Q000235:genetics; D050197:Atherosclerosis / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D002940:Circadian Rhythm / Q000235:genetics*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications* / Q000235:genetics / Q000503:physiopathology*; D050356:Lipid Metabolism / Q000235:genetics; D008099:Liver / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013194:Staining and Labeling; D013493:Suprachiasmatic Nucleus / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism
chemical_list: D001057:Apolipoproteins E; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D012333:RNA, Messenger; D014157:Transcription Factors